COMPASS THERAPEUTICS INC (CMPX) Forecast, Price Target & Analyst Ratings

NASDAQ:CMPX • US20454B1044

Current stock price

5.03 USD
-0.18 (-3.45%)
At close:
3.8 USD
-1.23 (-24.45%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COMPASS THERAPEUTICS INC (CMPX).

Forecast Snapshot

Consensus Price Target

Price Target
$13.77
+ 173.76% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.10
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
87.27%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$13.77
Upside
+ 173.76%
From current price of $5.03 to mean target of $13.77, Based on 22 analyst forecasts
Low
$8.08
Median
$12.24
High
$31.50

Price Target Revisions

1 Month
-4.19%
3 Months
4.46%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for CMPX. The average price target is 13.77 USD. This implies a price increase of 173.76% is expected in the next year compared to the current price of 5.03.
The average price target has been revised upward by 4.46% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CMPX Current Analyst RatingCMPX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

CMPX Historical Analyst RatingsCMPX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
87.27%
CMPX was analyzed by 22 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about CMPX.
In the previous month the buy percentage consensus was at a similar level.
CMPX was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-24GuggenheimReiterate Buy -> Buy
2026-01-06D. Boral CapitalMaintains Buy -> Buy
2026-01-05William BlairInitiate Outperform
2025-12-03CitizensInitiate Market Outperform
2025-12-03Cantor FitzgeraldInitiate Overweight
2025-12-03Canaccord GenuityInitiate Buy
2025-11-05D. Boral CapitalMaintains Buy -> Buy
2025-10-06LifeSci CapitalInitiate Outperform
2025-08-12D. Boral CapitalMaintains Buy -> Buy
2025-08-12GuggenheimMaintains Buy -> Buy
2025-07-01Raymond JamesReiterate Outperform
2025-05-09GuggenheimMaintains Buy -> Buy
2025-04-28D. Boral CapitalMaintains Buy -> Buy
2025-04-22GuggenheimReiterate Buy -> Buy
2025-04-21D. Boral CapitalMaintains Buy -> Buy
2025-04-21HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-04HC Wainwright & Co.Maintains Buy -> Buy
2025-04-02Leerink PartnersUpgrade Market Perform -> Outperform
2025-04-02GuggenheimReiterate Buy -> Buy
2025-04-01D. Boral CapitalMaintains Buy -> Buy
2025-02-27D. Boral CapitalMaintains Buy -> Buy
2025-02-25D. Boral CapitalMaintains Buy -> Buy
2025-02-24GuggenheimInitiate Buy
2025-02-19Piper SandlerInitiate Overweight
2025-02-10JefferiesMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.10
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
17.30%
Number of Analysts
18

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.72%
EPS (3 Months)
10.83%

Next Earnings Summary

CMPX is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.1 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CMPX revenue by date.CMPX revenue by date.
850K
-100.00%		6.015M62.22M
934.41%		218.28M
250.82%		401.54M
83.96%		634.69M
58.06%		961.92M
51.56%		1.443B
50.01%		1.958B
35.69%
EBITDA
YoY % growth
CMPX ebitda by date.CMPX ebitda by date.
-40.88M
49.72%		-49.664M
-21.49%		-56.036M
-12.83%		-78.576M
-27.36%		-85.221M
-19.41%		-81.192M
4.73%		-100.062M
-23.24%		28.325M
128.31%		123.95M
337.60%		167.63M
35.24%		211.1M
25.93%		226.52M
7.30%
EBIT
YoY % growth
CMPX ebit by date.CMPX ebit by date.
-41.66M
49.12%		-50.363M
-20.89%		-56.625M
-12.43%		-74.453M
-28.63%		-81.869M
-12.40%		-100.328M
-22.55%		-27.783M
72.31%		119.12M
528.76%		279.66M
134.77%		756.1M
170.36%		1.193B
57.78%		1.556B
30.43%
Operating Margin
CMPX operating margin by date.CMPX operating margin by date.
N/AN/A-6,661.76%N/A-1,361.08%-161.25%-12.73%29.67%44.06%78.60%82.67%79.47%
EPS
YoY % growth
CMPX eps by date.CMPX eps by date.
-0.37
69.70%		-0.34
8.11%		-0.37
-8.82%		-0.43
-16.22%		-0.41
4.90%		-0.50
-21.30%		0.09
118.03%		0.48
441.80%		1.21
150.29%		3.17
161.44%		4.44
39.95%		5.41
21.88%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.10
17.30%		-0.10
29.79%		-0.11
-34.78%		-0.10
-15.03%		-0.12
-24.03%		-0.14
-47.19%		-0.12
-10.05%		-0.08
24.63%		0.00
98.34%		0.03
123.62%		0.06
150.72%		0.09
211.76%
Revenue
Q2Q % growth		2.131M4.637M7.024M
229.61%		23.725M
411.65%		35.119M52.683M70.237M
899.96%		87.802M
270.08%
EBITDA
Q2Q % growth		-20.196M
-16.13%		-20.604M
-1.32%		-21.624M
-46.95%		-22.746M
-37.70%		-21.42M
-6.06%		-19.38M
5.94%		-14.28M
33.96%		-6.12M
73.09%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-19.568M
-17.81%		-20.043M
4.86%		-23.098M
-46.03%		-21.964M
-22.09%		-27.125M
-38.62%		-33.5M
-67.14%		-29.65M
-28.36%		-19.698M
10.31%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CMPX Yearly Revenue VS EstimatesCMPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
CMPX Yearly EPS VS EstimatesCMPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
30.22%
EPS Next 5 Year
36.97%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-10.36%
EBIT Next 5 Year
29.66%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

COMPASS THERAPEUTICS INC / CMPX Forecast FAQ

Can you provide the average price target for COMPASS THERAPEUTICS INC stock?

22 analysts have analysed CMPX and the average price target is 13.77 USD. This implies a price increase of 173.76% is expected in the next year compared to the current price of 5.03.

Can you provide the upcoming earnings date for COMPASS THERAPEUTICS INC?

COMPASS THERAPEUTICS INC (CMPX) will report earnings on 2026-05-13.

What are the consensus estimates for COMPASS THERAPEUTICS INC (CMPX) next earnings?

The consensus EPS estimate for the next earnings of COMPASS THERAPEUTICS INC (CMPX) is -0.1 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed COMPASS THERAPEUTICS INC (CMPX)?

The number of analysts covering COMPASS THERAPEUTICS INC (CMPX) is 22.